Clinical Trial

Dupixent Study for Alternate Administration

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 17, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
Investigators will investigate an alternate Dupilumab administration schedule in patients with recurrent chronic rhinosinusitis with nasal polyposis, who have a history of full endoscopic sinus surgery and are on appropriate topical medical therapies. Specifically, investigators will investigate if the alternate schedule of drug administration is non-inferior in both subjective and objective outcomes.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-19.
Trial Details
NCT Number NCT06750471
Lead Sponsor Madigan Army Medical Center
Collaborators: Tripler Army Medical Center, Fort Belvoir Community Hospital, William Beaumont Army Medical Center
Conditions Nasal Polyps, Sinusitis, Chronic Disease
Enrollment 30 participants
Start Date 2021-10-14
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-01-17